TrialBlood2019

The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.

Alexandre V Hirayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.